Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response
Yago González-Lama, Antonio López-San Román, Ignacio Marín-Jiménez, Begoña Casis, Isabel Vera, Fernando Bermejo, José Lázaro Pérez-Calle, Carlos Taxonera, Francisca Martínez-Silva, Luis Menchén, PilarVolume:
31
Year:
2008
DOI:
10.1157/13125587
File:
PDF, 98 KB
2008